Drug Profile
Research programme: small molecule antiviral therapeutics - Functional Genetics
Alternative Names: FGI-102-100; FGI-103-723Latest Information Update: 01 Dec 2014
Price :
$50
*
At a glance
- Originator Functional Genetics
- Class Small molecules
- Mechanism of Action Caspase inhibitors; Protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Ebola virus infections; Hepatitis B; Hepatitis C; HIV infections; Respiratory syncytial virus infections
Most Recent Events
- 01 Dec 2014 Discontinued - Preclinical for Ebola virus infections in USA (unspecified route)
- 01 Dec 2014 Discontinued - Preclinical for Hepatitis B in USA (unspecified route)
- 01 Dec 2014 Discontinued - Preclinical for Hepatitis C in USA (unspecified route)